Evaluation of 48 cases of orbital exenteration.
D000230:Adenocarcinoma / Q000601:surgery; D000328:Adult; D000368:Aged; D002280:Basal Cell Carcinoma / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D005134:Eye Neoplasms / Q000601:surgery; D005142:Eyelid Neoplasms / Q000601:surgery; D005260:Female; D005354:Fibrosarcoma / Q000601:surgery; D005500:Follow-Up Studies; D006099:Granuloma / Q000601:surgery; D006801:Humans; D007223:Infant; D007765:Lacrimal Apparatus; D008228:Lymphoma, Non-Hodgkin / Q000601:surgery; D008297:Male; D008545:Melanoma / Q000601:surgery; D008875:Middle Aged; D009369:Neoplasms / Q000601:surgery; D009373:Neoplasms, Germ Cell and Embryonal / Q000601:surgery; D009915:Orbit / Q000601:surgery*; D009918:Orbital Neoplasms / Q000401:mortality / Q000601:surgery*; D011878:Radiotherapy; D012208:Rhabdomyosarcoma / Q000601:surgery; D012509:Sarcoma / Q000601:surgery; D012878:Skin Neoplasms / Q000601:surgery